Skip to main content
MYUNGMOON PHARM CO.,LTD logo

MYUNGMOON PHARM CO.,LTD — Investor Relations & Filings

Ticker · 017180 ISIN · KR7017180001 KO Manufacturing
Open in API
Filings indexed 248 across all filing types
Latest filing 2026-03-11 Proxy Solicitation & In…
Country KR South Korea
Listing KO 017180

About MYUNGMOON PHARM CO.,LTD

http://mmpharm.co.kr/en/main/

Myungmoon Pharm Co., Ltd. is a research-based pharmaceutical company engaged in the development, manufacturing, and commercialization of healthcare products. The company produces over 250 specialized and general medicines, holding more than 400 manufacturing licenses. Its portfolio includes both ethical (ETC) and over-the-counter (OTC) drugs, with key product areas in anesthetics, digestive agents, and antitussives. The company's operations encompass the wholesale, import, and export of its pharmaceutical products for domestic and international markets.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains detailed information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures (electronic/written), and the company's financial statements (balance sheet, income statement, etc.) for the fiscal year. This is a standard proxy solicitation document used to request shareholder votes for an AGM.
2026-03-11 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Myungmoon Pharm Co., Ltd. It contains the agenda for the 40th Annual General Meeting, including items such as the approval of financial statements, election of directors, and remuneration limits. It also includes detailed management information, board activity reports, and financial statements (balance sheet, income statement) as part of the proxy materials provided to shareholders. This document is a standard Proxy Solicitation & Information Statement (PSI) used to inform shareholders of upcoming meeting details and solicit their votes.
2026-03-11 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Shareholders' Meeting (주주총회소집결의) for Myungmoon Pharm. It outlines the meeting date, location, agenda items (such as financial statement approval, director appointments, and remuneration limits), and details regarding the board's resolution. This type of document is a standard proxy solicitation/information statement provided to shareholders to inform them of upcoming meeting agendas and request their participation/votes.
2026-03-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. It details the acquisition of shares by an executive (Lim Gi-sub) of Myungmoon Pharm Co., Ltd. through market purchases. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) as it reports insider transactions by company management.
2026-02-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the acquisition of shares by an executive (Lim Gi-sub) of Myungmoon Pharm Co., Ltd. This type of filing, which reports personal share transactions by company directors and executives, is classified as 'Director's Dealing'.
2026-02-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details a specific transaction (장내매수 - open market purchase) of shares by an executive (이경희). This type of filing is a standard disclosure for insider trading/shareholding changes by company directors or major shareholders, which corresponds to the 'Director's Dealing' category.
2026-01-09 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.